Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CAPTOR-BC: Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients

NCT05452213 is registered in ClinicalTrials.gov with Institut fuer Frauengesundheit as lead sponsor.

NCT NCT05452213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05452213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CAPTOR-BC: Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients
Lead sponsor
Institut fuer Frauengesundheit
Phase
Phase 4
Overall status
Recruiting
Start date
October 12, 2022
Completion date
October 31, 2026
Enrollment
1,000 (estimated)
Sites
52

Conditions

As the registry lists them; a condition with its own page is linked.

advanced breast cancer, breast cancer, breast cancer female, breast neoplasm female, breast neoplasms, her2-negative breast cancer, hormone receptor-positive breast cancer